161 related articles for article (PubMed ID: 3005438)
1. Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
Kitchen L; Malone G; Orgad S; Barin F; Zaizov R; Ramot B; Gazit E; Kreiss J; Leal M; Wichmann I
J Infect Dis; 1986 Apr; 153(4):788-90. PubMed ID: 3005438
[No Abstract] [Full Text] [Related]
2. Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs.
Kloster BE; Tomar RH; Stockman JA; Lamberson HV; Merl SA; John PA; Groth DM; Poiesz BJ
Am J Clin Pathol; 1985 Apr; 83(4):450-6. PubMed ID: 2984918
[TBL] [Abstract][Full Text] [Related]
3. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
4. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV).
Barin F; Denis F; Baillou A; Leonard G; Mounier M; M'Boup S; Gershy-Damet G; Sangare A; Kanki P; Essex M
J Virol Methods; 1987 Aug; 17(1-2):55-61. PubMed ID: 2444614
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
Wang JJ; Steel S; Wisniewolski R; Wang CY
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
[TBL] [Abstract][Full Text] [Related]
6. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
Ohta M; Ohta K; Mori F; Nishitani H; Saida T
J Immunol; 1986 Dec; 137(11):3440-3. PubMed ID: 3023483
[TBL] [Abstract][Full Text] [Related]
7. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
Muncunill J; Forteza A; Forner N; Forteza-Rei J
Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
[No Abstract] [Full Text] [Related]
8. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
[TBL] [Abstract][Full Text] [Related]
9. Abnormality of helper/suppressor T cell ratio in patients with hemophilia.
Yasuda K; Matsumoto K; Okubo K; Yokoyama MM; Hiyoshi Y; Natori H
J Clin Lab Immunol; 1985 Jan; 16(1):27-30. PubMed ID: 2984427
[TBL] [Abstract][Full Text] [Related]
10. Serological characterization of HTLV-III infection in AIDS and related disorders.
Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
[TBL] [Abstract][Full Text] [Related]
11. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
12. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men.
Rinaldo CR; Kingsley LA; Lyter DW; Rabin BS; Atchison RW; Bodner AJ; Weiss SH; Saxinger WC
J Infect Dis; 1986 Oct; 154(4):556-61. PubMed ID: 3018092
[TBL] [Abstract][Full Text] [Related]
13. Development and early natural history of HTLV-III antibodies in persons with hemophilia.
Eyster ME; Goedert JJ; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA
JAMA; 1985 Apr; 253(15):2219-23. PubMed ID: 2983132
[TBL] [Abstract][Full Text] [Related]
14. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986.
Garsia RJ; Gatenby PA; Basten A; Kenny DF; Gallagher KJ; Rickard KA; Gust ID; Maskill W
Aust N Z J Med; 1987 Aug; 17(4):371-8. PubMed ID: 2963611
[TBL] [Abstract][Full Text] [Related]
15. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.
Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG
Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054
[TBL] [Abstract][Full Text] [Related]
16. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
Barin F; McLane MF; Allan JS; Lee TH; Groopman JE; Essex M
Science; 1985 May; 228(4703):1094-6. PubMed ID: 2986291
[TBL] [Abstract][Full Text] [Related]
17. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
[TBL] [Abstract][Full Text] [Related]
18. Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection.
Cao YZ; Valentine F; Hojvat S; Allain JP; Rubinstein P; Mirabile M; Czelusniak S; Leuther M; Baker L; Friedman-Kien AE
Blood; 1987 Aug; 70(2):575-8. PubMed ID: 2886162
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of isolated HIV anti-p24 reactivity in Western blot analysis.
Lelie PN; van der Poel CL; Reesink HW
Lancet; 1987 Mar; 1(8533):632. PubMed ID: 2881168
[No Abstract] [Full Text] [Related]
20. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
Allan JS; Coligan JE; Barin F; McLane MF; Sodroski JG; Rosen CA; Haseltine WA; Lee TH; Essex M
Science; 1985 May; 228(4703):1091-4. PubMed ID: 2986290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
